Cellular and molecular regulation of eosinophil trafficking to the lung

Immunology and Cell Biology

Volumn 76, Issue 5, 1998, Pages 454-460

  Hogan, Simon P ^a   Mould, Arne W ^a   Young, Janine M ^a   Rothenberg, Marc E ^b   Ramsay, Alistair J ^a   Matthaei, Klaus ^a   Young, Ian G ^a   Foster, Paul S ^a  

^a Biology and Environment   (Australia)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

CD4+ T lymphocytes and eosinophils; Eotaxin; Interleukin 4; Interleukin 5

Indexed keywords

CD4 ANTIGEN; EOTAXIN; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; EOSINOPHIL; EOSINOPHILIA; INFLAMMATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES, CC; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; IMMUNITY, CELLULAR; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; PULMONARY EOSINOPHILIA;

BRONCHUS;

EID: 0031759355     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00766.x     Document Type: Conference Paper

References (49)

1. Bochner B, Undem B, Lichtenstein L. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 1994; 12: 295-335.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
3. Carlos T, Harlan J. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
4. Hogan SP, Foster PS. Cytokines as targets for the inhibition of eosinophilic inflammation. Pharmacol. Ther. 1997; 74: 259-83.
5. Robinson D, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992; 326: 298-304.
6. Finkelman F, Katona I, Urban J et al. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 1988; 141: 2335-41.
7. Rothenberg M, Luster A, Leder P. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin-4-induced tumor suppression. Proc. Natl Acad. Sci. USA 1995; 92: 8960-4
8. Pober J, Gimbrone Jr M, Lapierre L et al. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and gamma interferon. J. Immunol. 1986; 37: 1893-6.
9. Walsh G, Hartnell A, Wardlaw A, Kurihara K, Sanderson C, Kay A. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990; 71: 258-65.
10. Hamid Q, Azzawi M, Ying S. Interleukin-5 in the pathogenesis of asthma. J. Clin. Invest. 1991; 87: 1541-6.
11. Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 1988; 167: 1737-42.
12. Wang J, Rambaldi A, Biondi A, Chen Z, Sanderson C, Mantovani A. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 1989; 19: 701-5.
13. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 1996; 183: 195-201.
14. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 1994; 179: 751-6.
15. Rot A, Krieger M, Brunner T, Bischoff S, Schall T, Dahinden C. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 1992; 176: 1489-95.
16. Jose P, Griffiths-Johnson D, Collins P et al. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 1994; 179: 881-7.
17. Collins P, Marleau S, Griffiths-Johnson D, Jose P, Williams T. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 1995; 182: 1169-74.
18. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 1997; 99: 1064-71.
19. Lee J, McGarry M, Farmer S et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomic of asthma. J. Exp. Med. 1997; 185: 2143-56.
20. Kopf M, Brombacher K, Hodgkin P et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4: 15-24.
21. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am. J. Respir. Crit. Care Med. 1998; 157: 210-18.
22. Humbles A, Conroy D, Marleau S et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo. J. Exp. Med. 1997; 186: 601-12.
23. Rothenberg M, MacLean J, Pearlman E, Luster A, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 1997; 185: 785-90.
24. Sallusto F, Mackay C, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-7.
25. Corry D, Folkesson H, Warnock M et al. Interleukin-4, but not interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 1996; 183: 109-17.
26. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwells RA. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 1995; 12: 254-9.
27. Rankin J, Picarella D, Geba G et al. Phenotypic and physiologic characterisation of transgenic mice expressing interleukin-4 in the lung: Lymphocytic and eosinophilic inflammation with airway hyperreactivity. Proc. Natl Acad. Sci. USA 1996; 93: 7821-5.
28. Cohn L, Homer R, Marinov A, Rankin J, Bottomly K. Induction of airways mucus production by T helper 2 (Th2) cells: A critical role for interleukin-4 in cell recruitment but not mucus production. J. Exp. Med. 1997; 186: 1737-47.
29. Hogan SP, Mould AW, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 1997; 99: 1329-39.
30. Mehlhop P, van de Rijn M, Goldberg A et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl Acad. Sci. USA 1997; 94: 1344-9.
31. Takeda K, Hamelmann E, Joetham A et al. Development of eosinophilic airway inflammation and airway responsiveness in mast cell deficient mice. J. Exp. Med. 1997; 186: 449-54.
32. Zurawski G, de Vries J. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994; 15: 19-26.
33. Punnonen J, Aversa G, Cocks B et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl Acad. Sci. USA 1993; 90: 373-4.
34. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a nonanaphylactogenic anti-IgE antibody. J. Exp. Med. 1996; 183: 1303-10.
35. Gladue RP, Carroll LA, Milici AJ. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J. Exp. Med. 1996; 183: 1893-8.
36. Pozo VD, André BD, Martin E et al. Eosinophil as antigen presenting cell: Activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur. J. Immunol. 1992; 22: 1919-25.
37. Watanabe A, Mishima H, Renz PM, Xu LJ, Hamid Q, Martin JG. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in Brown Norway rats. J. Clin. Invest. 1995; 96: 1303-10.
38. Hamelmann E, Oshiba A, Paluh J. et al. Requirement for CD8+ T cells in the development of airways hyperresponsiveness in a murine model of airway sensitization. J. Exp. Med. 1996; 183: 1719-29.
39. Kennedy JD, Hatfield CA, Fidler SF et al. Phenotypic characterisation of T lymphocytes emigrating into lung tissue and the airway lumen after antigen inhalation in sensitised mice. Am. J. Respir. Cell Mol. Biol. 1995; 12: 613-23.
40. MacLean JA, Owenby R, Luster AD. T-cell dependent regulation of eotaxin in antigen induced pulmonary eosinophilia. J. Exp. Med. 1997; 184: 1461-9.
41. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 1995; 181: 1211-16.
42. Kopf M, Le-Gros G, Bachmann B, Lumers MC, Bluethman H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362: 245-7.
43. Coffman RL, Seymour BWP, Hudak S, Jackson J. Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245: 308-10.
44. von der Weid T, Kopf M, Kohler G, Langhorner J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 1994; 24: 2285-93.
45. Walker C, Bode F, Boer L, Hansel TT, Blaser K, Virchow J-C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 1992; 146: 109-15.
46. Noben-Trauth N, Shultz L, Brombacher F, Urban Jr J, Gu H, Paul W. An interleukin4 (IL-4) -independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 1997; 94: 10 838-43.
47. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T-cell regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of interleukin -4 and -5. J. Immunol. 1998; 161: 1501-9.
48. Gavett S, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 1994; 10: 587-93.
49. De Sanctis G, Itoh A, Green F et al. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 1997; 3: 460-2.